BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS)

CUSIP: G11217117

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / CLASS A ORD SHS
Total 13F shares
17,574,000
Share change
+17,173,900
Total reported value
$173,634,000
Price per share
$9.88
Number of holders
56
Value change
+$169,681,000
Number of buys
55

Quarterly Holders Quick Answers

What is CUSIP G11217117?
CUSIP G11217117 identifies BIOS - BIOPLUS ACQUISITION CORP - CLASS A ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS) as of Q1 2022

As of 31 Mar 2022, BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,574,000 shares. The largest 10 holders included Saba Capital Management, L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, Linden Advisors LP, MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, D. E. Shaw & Co., Inc., Polar Asset Management Partners Inc., MMCAP International Inc. SPC, AQR Arbitrage LLC, and Starboard Value LP. This page lists 56 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.